SCHEMBL21847174

SCHEMBL21847174

Cc1cc(C(=O)c2ccc(Cl)cc2)c(N=C=S)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
MAPT P10636 5/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 2/20 0.51
HTT P42858 2/20 0.51
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
POLB P06746 1/20 0.42
RAB9A P51151 3/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
NR4A1 P22736 1/20 0.39
NPC1 O15118 1/20 0.38
PRNP P04156 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
ADORA1 P30542 1/20 0.37
SRD5A2 P31213 2/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8318417 0.79 MAPT (0.45) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL11848681 0.77 MAPT (0.59) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL21847322 0.77 RAB9A (0.55) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL21847257 0.75 HPGD (0.40) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL21847326 0.75 MAPT (0.77) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL23319960 0.71 ALDH1A1 (0.63) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL8318162 0.71 NR4A1 (0.54) ALDH1A1MAPTLMNAHTTL3MBTL1
SCHEMBL21847222 0.67 ALDH1A1 (0.41) ALDH1A1MAPTSMN1; SMN2LMNAHTT
SCHEMBL21847220 0.67 NR4A1 (0.45) ALDH1A1MAPTSMN1; SMN2LMNAL3MBTL1
SCHEMBL10627982 0.67 SRD5A2 (0.56) ALDH1A1MAPTSMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110914280-B 6H-thieno [2,3-e ] [1,2,4] triazolo [3,4-c ] [1,2,4] triazab derivatives 阿尤米制药公司 2024-05-03 CN disclosed
US-11186588-B2 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative AYUMI PHARMACEUTICAL CORPORATION (JP) 2021-11-30 US disclosed
US-11186588-B2 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative AYUMI PHARMACEUTICAL CORPORATION (JP) 2021-11-30 US disclosed
US-20210130367-A1 6H-THIENO[2,3-e][1,2,4]TRIAZOLO[3,4-c][1,2,4]TRIAZEPINE DERIVATIVE AYUMI PHARMACEUTICAL CORPORATION (JP) 2021-05-06 US disclosed
US-20210130367-A1 6H-THIENO[2,3-e][1,2,4]TRIAZOLO[3,4-c][1,2,4]TRIAZEPINE DERIVATIVE AYUMI PHARMACEUTICAL CORPORATION (JP) 2021-05-06 US disclosed
EP-3640253-A1 6H-THIENO[2,3-E][1,2,4]TRIAZOLO[3,4-C][1,2,4]TRIAZEPINE DERIVATIVE AYUMI Pharmaceutical Corporation (JP) 2020-04-22 EP disclosed
EP-3640253-A1 6H-THIENO[2,3-E][1,2,4]TRIAZOLO[3,4-C][1,2,4]TRIAZEPINE DERIVATIVE AYUMI Pharmaceutical Corporation (JP) 2020-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130367-A1 6H-THIENO[2,3-e][1,2,4]TRIAZOLO[3,4-c][1,2,4]TRIAZEPINE DERIVATIVE BRD4, BRD3, BRD2 ALDH1A1 3279/4885MAPT 1675/4885SMN1; SMN2 3608/4885
US-11186588-B2 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative BRD4, BRD3, BRD2 ALDH1A1 3279/4885MAPT 1675/4885SMN1; SMN2 3608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.